BioCentury
ARTICLE | Company News

Pernix Therapeutics, SePRO sales and marketing update

August 22, 2011 7:00 AM UTC

SePRO's ParaPRO LLC subsidiary and Pernix launched ParaPRO's Natroba spinosad topical 0.9% in the U.S. to treat head lice in patients four years of age and older. The wholesale acquisition cost is $2...